A multimodal marker for cognitive functioning in multiple sclerosis: the role of NfL, GFAP and conventional MRI in predicting cognitive functioning in a prospective clinical cohort

Autor: Maureen van Dam, Brigit A. de Jong, Eline A. J. Willemse, Ilse M. Nauta, Marijn Huiskamp, Martin Klein, Bastiaan Moraal, Sanne de Geus-Driessen, Jeroen J. G. Geurts, Bernard M. J. Uitdehaag, Charlotte E. Teunissen, Hanneke E. Hulst
Přispěvatelé: Anatomy and neurosciences, Amsterdam Neuroscience - Neuroinfection & -inflammation, Neurology, APH - Quality of Care, Neurochemistry Laboratory, Medical psychology, CCA - Cancer Treatment and quality of life, Radiology and nuclear medicine, Amsterdam Neuroscience - Neurodegeneration
Jazyk: angličtina
Rok vydání: 2023
Předmět:
Zdroj: Journal of Neurology. D. Steinkopff-Verlag
van Dam, M, de Jong, B A, Willemse, E A J, Nauta, I M, Huiskamp, M, Klein, M, Moraal, B, de Geus-Driessen, S, Geurts, J J G, Uitdehaag, B M J, Teunissen, C E & Hulst, H E 2023, ' A multimodal marker for cognitive functioning in multiple sclerosis : the role of NfL, GFAP and conventional MRI in predicting cognitive functioning in a prospective clinical cohort ', Journal of Neurology, vol. 270, no. 8 . https://doi.org/10.1007/s00415-023-11676-4
ISSN: 0340-5354
DOI: 10.1007/s00415-023-11676-4
Popis: Background Cognitive impairment in people with MS (PwMS) has primarily been investigated using conventional imaging markers or fluid biomarkers of neurodegeneration separately. However, the single use of these markers do only partially explain the large heterogeneity found in PwMS. Objective To investigate the use of multimodal (bio)markers: i.e., serum and cerebrospinal fluid (CSF) levels of neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) and conventional imaging markers in predicting cognitive functioning in PwMS. Methods Eighty-two PwMS (56 females, disease duration = 14 ± 9 years) underwent neuropsychological and neurological examination, structural magnetic resonance imaging, blood sampling and lumbar puncture. PwMS were classified as cognitively impaired (CI) if scoring ≥ 1.5SD below normative scores on ≥ 20% of test scores. Otherwise, PwMS were defined as cognitively preserved (CP). Association between fluid and imaging (bio)markers were investigated, as well as binary logistics regression to predict cognitive status. Finally, a multimodal marker was calculated using statistically important predictors of cognitive status. Results Only higher NfL levels (in serum and CSF) correlated with worse processing speed (r = − 0.286, p = 0.012 and r = − 0.364, p = 0.007, respectively). sNfL added unique variance in the prediction of cognitive status on top of grey matter volume (NGMV), p = 0.002). A multimodal marker of NGMV and sNfL yielded most promising results in predicting cognitive status (sensitivity = 85%, specificity = 58%). Conclusion Fluid and imaging (bio)markers reflect different aspects of neurodegeneration and cannot be used interchangeably as markers for cognitive functioning in PwMS. The use of a multimodal marker, i.e., the combination of grey matter volume and sNfL, seems most promising for detecting cognitive deficits in MS.
Databáze: OpenAIRE
Externí odkaz: